-
Regulatory December 2, 2021Nomination Committee appointed for the 2022 Annual General Meeting in Oasmia
-
Non Regulatory November 26, 2021Oasmia to present at the Erik Penser Bank Life Science Day on December 2
-
Non Regulatory November 26, 2021Oasmia to present at Stora Aktiedagen Stockholm on December 2
Oasmia Pharmaceutical published its Q3 2021 report on November 18, 2021, at 08.00 am CET.
The company will hold a conference call and an online presentation on the same day at 10.00 am CET. The call will be hosted by CEO Francois Martelet and CFO Fredrik Järrsten. The presentation will be in English.
Oasmia acquires global development and commercialization rights for Cantrixil, a clinical stage, ovarian cancer program
;
We very much enjoyed attending @Aktiespararna's event Stora Aktiedagen Stockholm 2021 earlier today. You can catch up on our presentation and an update on our recent progress given by Oasmia’s CEO, Francois Martelet, here:
#oncology #QandA
Oasmia Pharmaceuticals â Stora Aktiedagen Stockholm 2 december 2021
CEO Francois Martelet presenterar bolagetDisclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en m&...
bit.ly
